ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
69,714.17
0.88%
S&P 500
5,307.01
-0.27%
Dow Jones
39,671.04
-0.51%
US Dollar vs Yen
156.697
-0.01%
Brent Oil
82.355
1.01%
Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. bioAffinity Technologies Inc (BIAF)

  7. bioAffinity Technologies Inc (BIAF) ニュース

BIAF

bioAffinity Technologies (BIAF)

bioAffinity Technologies Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:BIAF
日付受信時刻ニュースソース見出しコード企業名
2024/05/1522 : 15Business WirebioAffinity Technologies Reports Record Q1 Revenue Driven by Accelerating Growth of CyPath® Lung Sales and Increased Laboratory VolumesNASDAQ:BIAFbioAffinity Technologies Inc
2024/05/0221 : 00Business WirebioAffinity Technologies News UpdateNASDAQ:BIAFbioAffinity Technologies Inc
2024/04/2421 : 00Business WirebioAffinity Technologies Advances New Product Development Initiatives to Accelerate Next Phase of GrowthNASDAQ:BIAFbioAffinity Technologies Inc
2024/04/0921 : 00Business WirebioAffinity Technologies Expands Campaign to Support American Cancer Society Initiative for Lung Cancer ScreeningNASDAQ:BIAFbioAffinity Technologies Inc
2024/04/0122 : 49Business WirebioAffinity Technologies Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:BIAFbioAffinity Technologies Inc
2024/03/0907 : 00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BIAFbioAffinity Technologies Inc
2024/03/0903 : 15PR Newswire (US)Wallachbeth Capital Announces Closing of bioAffinity Technologies $2.5 Million Registered Direct Offering and Concurrent Private PlacementNASDAQ:BIAFbioAffinity Technologies Inc
2024/03/0902 : 45Business WirebioAffinity Technologies Announces Closing of $2.5 Million Registered Direct Offering and Concurrent Private PlacementNASDAQ:BIAFbioAffinity Technologies Inc
2024/03/0902 : 18Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:BIAFbioAffinity Technologies Inc
2024/03/0811 : 57Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:BIAFbioAffinity Technologies Inc
2024/03/0700 : 45PR Newswire (US)WallachBeth Capital Announces Pricing of BioAffinity Technologies $2.5 Million Registered Direct Offering and Concurrent Private PlacementNASDAQ:BIAFbioAffinity Technologies Inc
2024/03/0623 : 46Business WirebioAffinity Technologies Announces Pricing of $2.5 Million Registered Direct Offering and Concurrent Private PlacementNASDAQ:BIAFbioAffinity Technologies Inc
2024/03/0607 : 26Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BIAFbioAffinity Technologies Inc
2024/03/0522 : 00Business WirebioAffinity Technologies Reports Accelerating Sales Growth of CyPath® LungNASDAQ:BIAFbioAffinity Technologies Inc
2024/02/2122 : 00Business WirebioAffinity Technologies News UpdateNASDAQ:BIAFbioAffinity Technologies Inc
2024/02/0622 : 00Business WireMedical Director of Lung Innovations Network and The Lung Center at Penn Highlands Healthcare, Sandeep Bansal, M.D., Joins bioAffinity Technologies’ Medical and Scientific Advisory Board and Incorporates CyPath® Lung into Medical PracticeNASDAQ:BIAFbioAffinity Technologies Inc
2024/02/0306 : 25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BIAFbioAffinity Technologies Inc
2024/02/0306 : 22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BIAFbioAffinity Technologies Inc
2024/02/0306 : 21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BIAFbioAffinity Technologies Inc
2024/02/0306 : 17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BIAFbioAffinity Technologies Inc
2024/02/0106 : 05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BIAFbioAffinity Technologies Inc
2024/01/3022 : 00Business WirebioAffinity Technologies In The NewsNASDAQ:BIAFbioAffinity Technologies Inc
2024/01/2510 : 52Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BIAFbioAffinity Technologies Inc
2024/01/2510 : 52Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BIAFbioAffinity Technologies Inc
2024/01/2510 : 52Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BIAFbioAffinity Technologies Inc
2024/01/2322 : 00Business WirebioAffinity Technologies Announces Award of Therapeutic Patent for Treatment of CancerNASDAQ:BIAFbioAffinity Technologies Inc
2024/01/0822 : 00Business WirebioAffinity Technologies In the NewsNASDAQ:BIAFbioAffinity Technologies Inc
2023/12/0906 : 06Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:BIAFbioAffinity Technologies Inc
2023/12/0522 : 45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BIAFbioAffinity Technologies Inc
2023/12/0522 : 00Business WirebioAffinity Technologies Appoints Jamie Platt, Ph.D., to its Board of DirectorsNASDAQ:BIAFbioAffinity Technologies Inc
 Showing the most relevant articles for your search:NASDAQ:BIAF

最近閲覧した銘柄

EU
9342T
9342T
BIT
P1WE18
NLBNPIT1WE18 20240621 2.4
BIT
UC41KW
Unicredit Bank
LSE
0K62
LBNK
YOYOWETH
YOYOW
NYSE
OPP-B
RiverNorth DoubleLine St...
COIN
LUXUSD
AMEX
NUBD
Nuveen ESG US Aggregate ...
EU
BEAR00423382
Aspa
ASX
PNV
Polynovo
BIT
UC8VLR
Unicredit Bank
COIN
ALEXETH
BIT
UV8DA4
UniCredit Bank
BIT
UV4L84
UniCredit Bank
LSE
1011
LSE
2BUL
Wt Gold 2x
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有